Brief: First Patient Dosed With Lixte’S Lb-100 In New Clinical Trial To Treat Colorectal Cancer

NOMAD Power Solutions

26/08/2024 13:34

Aug 26 (Reuters) - Lixte Biotechnology Holdings Inc
 LIXT.O :
    * FIRST PATIENT DOSED WITH LIXTE’S LB-100 IN NEW CLINICAL
TRIAL TO
TREAT COLORECTAL CANCER, COLLABORATING WITH NKI, SUPPORTED BY
MAJOR PHARMA COMPANY

Source text for Eikon:  ID:nGNX1QWfql 
Further company coverage:  LIXT.O 

 ((Reuters.Briefs@thomsonreuters.com;))